The Brd4 Extraterminal Domain Confers Transcription Activation Independent of pTEFb by Recruiting Multiple Proteins, Including NSD3
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Bromodomain protein 4 (Brd4) plays critical roles in development, cancer progression, and virus-host pathogenesis. To gain mechanistic insight into the various biological functions of Brd4, we performed a proteomic analysis to identify and characterize Brd4-associated cellular proteins. We found that the extraterminal (ET) domain, whose function has to date not been determined, interacts with NSD3, JMJD6, CHD4, GLTSCR1, and ATAD5. These ET-domain interactions were also conserved for Brd2 and Brd3, the other human BET proteins tested. We demonstrated that GLTSCR1, NSD3, and JMJD6 impart a pTEFb-independent transcriptional activation function on Brd4. NSD3 as well as JMJD6 is recruited to regulated genes in a Brd4-dependent manner. Moreover, we found that depletion of Brd4 or NSD3 reduces H3K36 methylation, demonstrating that the Brd4/NSD3 complex regulates this specific histone modification. Our results indicate that the Brd4 ET domain through the recruitment of the specific effectors regulates transcriptional activity. In particular, we show that one of these effectors, NSD3, regulates transcription by modifying the chromatin microenvironment at Brd4 target genes. Our study thus identifies the ET domain as a second important transcriptional regulatory domain for Brd4 in addition to the carboxyl-terminal domain (CTD) that interacts with pTEFb.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“N-terminal bromodomains confer binding to acetylated histone H3 and H4 tails, while the C-terminal extraterminal domain interacts with chromatin modifying enzymes such as histone methyltransferase NSD3 (REF.119,120).”
From Structure and function of retroviral integrase (2022) · cites this paper as [120]
Citations
Cites
High-Resolution Profiling of Histone Methylations in the Human Genome
Barski, A., Cuddapah, S., Cui, K., Roh, T.-Y., Schones, D. E., Wang, Z., Wei, G., Chepelev, I., & Zhao, K. (2007) · Cell · doi:10.1016/j.cell.2007.05.009 · Cited by 6,845 · cited 1×
“H3K36me3 levels were higher within the coding region, peaking at the 3 end, than at the promoter in accordance with published findings (2).”
ResultDefining the Human Deubiquitinating Enzyme Interaction Landscape
Sowa, M. E., Bennett, E. J., Gygi, S. P., & Harper, J. W. (2009) · Cell · doi:10.1016/j.cell.2009.04.042 · Cited by 1,512
Self-citationCarrozza, M. J., Li, B., Florens, L., Suganuma, T., Swanson, S. K., Lee, K. K., Shia, W.-J., Anderson, S., Yates, J., Washburn, M. P., et al. (2005) · Cell · doi:10.1016/j.cell.2005.10.023 · Cited by 1,294 · cited 1×
“Studies ranging from yeast to humans suggest that methylated H3K36 is enriched in regions of active transcription and is linked to transcriptional elongation and productive transcription within coding regions (5, 48, 49, 53).”
BackgroundJang, M. K., Mochizuki, K., Zhou, M., Jeong, H.-S., Brady, J. N., & Ozato, K. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.027 · Cited by 1,291 · cited 3×
“Many different BET family members, including the yeast bdf1/bdf2, Drosophila fs(1)h, and the mammalian Brd2, Brd3, and Brd4 proteins, have been implicated in transcription regulation (11, 13, 24, 27, 32).”
BackgroundRecruitment of P-TEFb for Stimulation of Transcriptional Elongation by the Bromodomain Protein Brd4
Yang, Z., Yik, J. H. N., Chen, R., He, N., Jang, M. K., Ozato, K., & Zhou, Q. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.029 · Cited by 1,138 · cited 2×
“However, only the CTD, present solely in Brd4 and fs(1)h, has been rigorously documented to regulate transcription through its interaction with pTEFb (4, 24, 56).”
BackgroundXue, Y., Wong, J., Moreno, G. T., Young, M. K., Côté, J., & Wang, W. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80299-3 · Cited by 985 · cited 1×
“CHD4 was observed to interact with components of the NuRD corepressor complex also as predicted previously (54).”
BackgroundJMJD6 Is a Histone Arginine Demethylase
Chang, B., Chen, Y., Zhao, Y., & Bruick, R. K. (2007) · Science · doi:10.1126/science.1145801 · Cited by 745 · cited 1×
“It was initially reported to be a histone arginine demethylase, responsible for H3R2me and H4R3me modifications (6).”
BackgroundControl of Inducible Gene Expression by Signal-Dependent Transcriptional Elongation
Hargreaves, D. C., Horng, T., & Medzhitov, R. (2009) · Cell · doi:10.1016/j.cell.2009.05.047 · Cited by 644 · cited 2×
“A recent study demonstrates that transcription of primary responsive genes in stimulated macrophages is dependent on Brd4 and is linked to production of mature spliced transcripts (19).”
BackgroundBRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma.
French, C. A., Miyoshi, I., Kubonishi, I., Grier, H. E., Pérez‐Atayde, A. R., & Fletcher, J. A. (2003) · PubMed · Cited by 501
The human Mi-2/NuRD complex and gene regulation
Denslow, S. A., & Wade, P. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210611 · Cited by 478 · cited 1×
“Notably, evidence suggests that it is involved in repression of genes that are regulated by estrogen receptor (12).”
Background
Research works printed but not linked: 2
- Denis G. V., 2000, Cell Growth Differ, 11, 417
- French C. A., 2003, Cancer Res, 63, 304
Cited by
Items 101–200 of 554
Two faces of BRD4: Mitotic bookmark and transcriptional lynchpin
Devaiah, B. N., & Singer, D. S. (2013) · Transcription · doi:10.4161/trns.22542 · Cited by 97
Dooley, K. E., Warburton, A., & McBride, A. A. (2016) · mBio · doi:10.1128/mbio.01446-16 · Cited by 87
“Brd4 is classically an activator of transcription and promotes transcriptional elongation by interaction with pTEFb (30) and through a number of factors that bind the ET region (31).”
Jeong, G., Park, M. K., Choi, H., An, H. W., Park, Y.-U., Choi, H.-J., Park, J. H., Kim, H.-Y., Son, T., Lee, H., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0360 · Cited by 88
“NSD3 was also reported to be preferentially recruited to promoter regions, despite the highly enriched H3K36me3 levels at the gene bodies (48).”
BackgroundTranscriptional Pause Release Is a Rate-Limiting Step for Somatic Cell Reprogramming
Liu, L., Xu, Y., He, M., Zhang, M., Cui, F., Lu, L., Yao, M., Tian, W., Benda, C., Zhuang, Q., et al. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.09.018 · Cited by 92
Wang, X., Helfer, C. M., Pancholi, N., Bradner, J. E., & You, J. (2013) · Journal of Virology · doi:10.1128/jvi.03068-12 · Cited by 84
BET Protein Inhibitor JQ1 Attenuates Myc-Amplified MCC Tumor Growth In Vivo
Shao, Q., Kannan, A., Lin, Z., Stack, B. C., Suen, J. Y., & Gao, L. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0305 · Cited by 92
RORα is crucial for attenuated inflammatory response to maintain intestinal homeostasis
Oh, S. K., Kim, D., Kim, K., Boo, K., Yu, Y. S., Kim, I. S., Jeon, Y., Im, S.-K., Lee, S.-H., Lee, J. M., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1907595116 · Cited by 85
SPOP-containing complex regulates SETD2 stability and H3K36me3-coupled alternative splicing
Zhu, K., Lei, P., Ju, L., Wang, X., Huang, K., Yang, B., Shao, C., Zhu, Y., Wei, G., Fu, X., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw814 · Cited by 86
Mills, A. A. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026450 · Cited by 89
“CHD4 interacts with BRD4/NSD3 (Rahman et al. 2011), ZFHX4 (Chudnovsky et al.”
Transcription factor protein interactomes reveal genetic determinants in heart disease
Gonzalez-Teran, B., Pittman, M., Felix, F., Thomas, R., Richmond-Buccola, D., Hüttenhain, R., Choudhary, K., Moroni, E., Costa, M. W., Huang, Y., et al. (2022) · Cell · doi:10.1016/j.cell.2022.01.021 · Cited by 81
c-MYC—Making Liver Sick: Role of c-MYC in Hepatic Cell Function, Homeostasis and Disease
Zheng, K., Cubero, F., & Nevzorova, Y. (2017) · Genes · doi:10.3390/genes8040123 · Cited by 84
“Members of the bromodomain and extraterminal (BET) subfamily of bromodomain proteins associate with acetylated chromatin and facilitate transcriptional activation [90].”
BackgroundCrowe, B. L., Larue, R. C., Yuan, C., Hess, S., Kvaratskhelia, M., & Foster, M. P. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516813113 · Cited by 83
“Indeed, our site-directed mutagenesis and proteomic experiments indicate that the structural features of Brd4 important for binding by MLV IN are also important for binding to cellular proteins previously identified to interact with the ET domain, including NSD3, ATAD5, GLTSCR1, and CHD4 (Dataset S1), suggesting commo…”
BackgroundInfluentialThe Role of the DNA Damage Response throughout the Papillomavirus Life Cycle
McKinney, C., Hussmann, K., & McBride, A. (2015) · Viruses · doi:10.3390/v7052450 · Cited by 79
“There are hints that BRD4 might function in the DDR; it interacts with the DDR associated RFC1 subunit, ATAD5 [53], a minor isoform of BRD4 protects adjacent chromatin from DNA damage signaling [64], and we find that BRD4 is associated with aphidicolin inducible fragile sites in C-33A cells [43,64].”
BackgroundBRD9 Is a Critical Regulator of Androgen Receptor Signaling and Prostate Cancer Progression
Alpsoy, A., Utturkar, S. M., Carter, B. C., Dhiman, A., Torregrosa‐Allen, S. E., Currie, M. P., Elzey, B. D., & Dykhuizen, E. C. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-1417 · Cited by 84
Shen, Y. L., Chen, J.-Q., & Li, X. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2024.101374 · Cited by 96
“164 Currently, there are several NSD3 inhibitors such as BI-9321, MS9715, and SYL2158 that have demonstrated inhibitory effects in lung cancer.”
Structural Mechanism of Transcriptional Regulator NSD3 Recognition by the ET Domain of BRD4
Zhang, Q., Zeng, L., Shen, C., Ju, Y., Konuma, T., Zhao, C., Vakoc, C. R., & Zhou, M.-M. (2016) · Structure · doi:10.1016/j.str.2016.04.019 · Cited by 76
“NSD2/3 and CHD4 and other epigenetic proteins that were previously reported as Brd4 ET domain-associated proteins by Rahman et al. (2011) are among the list.”
InfluentialSupercharging BRD4 with NUT in carcinoma
Eagen, K. P., & French, C. A. (2021) · Oncogene · doi:10.1038/s41388-020-01625-0 · Cited by 82
“These include Mediator complex members [23], Transcription Factor IID complex members [23], Nuclear Receptor Binding SET Domain Proteins [10, 23, 24], and Chromodomain Helicase DNA Binding Proteins (CHD4,8) [23, 24].”
BackgroundResultChan, C., Fang, C., Qiao, Y., Yarilina, A., Prinjha, R. K., & Ivashkiv, L. B. (2014) · European Journal of Immunology · doi:10.1002/eji.201444862 · Cited by 84
Siu, K. T., Ramachandran, J., Yee, A. J., Eda, H., Santo, L., Panaroni, C., Mertz, J. A., Sims, R. J., Cooper, M. R., & Raje, N. S. (2016) · Leukemia · doi:10.1038/leu.2016.355 · Cited by 84
Sartor, G. C., Malvezzi, A. M., Kumar, A., Andrade, N. S., Wiedner, H. J., Vilca, S. J., Janczura, K. J., Bagheri, A., Al-Ali, H., Powell, S. K., et al. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.1604-18.2018 · Cited by 76
“This amino acid sequence was previously shown to be necessary for BRD4-mediated gene regulation and did not induce toxicity when expressed in cells (Rahman et al., 2011).”
BackgroundHölscher, A. S., Schulz, W. A., Pinkerneil, M., Niegisch, G., & Hoffmann, M. J. (2018) · Clinical Epigenetics · doi:10.1186/s13148-017-0434-3 · Cited by 80
“For BRD4 overexpression, cells were transfected with p6344 pcDNA4-TO-HA-Brd4FL (Addgene plasmid #31351) [18] or empty vector (pcDNA4-TO) using X-tremeGENE 9 DNA Transfection Reagent (Roche, Penzberg, Germany).”
MethodBET Proteins as Attractive Targets for Cancer Therapeutics
Sarnik, J., Popławski, T., & Tokarz, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011102 · Cited by 82
A Simple Cell-Based Assay Reveals That Diverse Neuropsychiatric Risk Genes Converge on Primary Cilia
Marley, A., & von Zastrow, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046647 · Cited by 76
“[28], we are not aware of previous evidence for physical or functional interaction between the hits identified in the present study.”
BackgroundThe Role of the Double Bromodomain-Containing BET Genes During Mammalian Spermatogenesis
Berkovits, B. D., & Wolgemuth, D. J. (2012) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-416024-8.00011-8 · Cited by 82
“A third report found that it was the CTD that bound P-TEFb and that both subunits, CDK9 and CCNT1, were bound (Rahman et al., 2011).”
BRD4 and MYC : power couple in transcription and disease
Kotekar, A., Singh, A. K., & Devaiah, B. N. (2022) · FEBS Journal · doi:10.1111/febs.16580 · Cited by 80
“BRD4 can also modify the chromatin environment by its interaction with other chromatin modifiers such as arginine demethylase JMJD6, lysine methyltransferase Nsd3, acetyltransferases p300/CBP [112] and ATP-dependent chromatin remodellers such as SWI/SNF, CHD8 and CHD4 [94,113,114].”
BackgroundBiomolecular condensates: Formation mechanisms, biological functions, and therapeutic targets
Niu, X., Zhang, L., Wu, Y., Zong, Z., Wang, B., Liu, J., Zhang, L., & Zhou, F. (2023) · MedComm · doi:10.1002/mco2.223 · Cited by 80
Brd4 Is Displaced from HPV Replication Factories as They Expand and Amplify Viral DNA
Sakakibara, N., Chen, D., Jang, M. K., Kang, D. W., Luecke, H. F., Wu, S.-Y., Chiang, C.-M., & McBride, A. A. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003777 · Cited by 76
“which is involved in the DNA damage response, binds to the ET domain of Brd4 [62].”
BackgroundArnold, M., Bressin, A., Jasnovidova, O., Meierhofer, D., & Mayer, A. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.06.026 · Cited by 83
The Histone Deacetylase SIRT6 Restrains Transcription Elongation via Promoter-Proximal Pausing
Etchegaray, J., Zhong, L., Li, C., Henriques, T., Ablondi, E. F., Nakadai, T., Rechem, C. V., Ferrer, C. M., Ross, K. N., Choi, J.-E., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.06.034 · Cited by 79
“BRD4 was shown to recruit the H3K36 methyltransferase NSD3 to increase gene expression (Rahman et al., 2011; Shen et al., 2015), while MYC interacts with DOT1L, the only known histone methyltransferase to catalyze methylation of H3K79, to induce transcription activation (Cho et al., 2015; Wong et…”
Brd4 and HEXIM1: Multiple Roles in P-TEFb Regulation and Cancer
Chen, R., Yik, J. H. N., Lew, Q. J., & Chao, S. (2014) · BioMed Research International · doi:10.1155/2014/232870 · Cited by 81
“The ET domain functions as a motif that interacts with WHSC1L1 (Wolf-Hirschhorn syndrome candidate 1-like 1 or NSD3) for the regulation of H3K36 methylation [44].”
BRD4 in physiology and pathology: ‘‘BET’’ on its partners
Liang, Y., Tian, J., & Wu, T. (2021) · BioEssays · doi:10.1002/bies.202100180 · Cited by 76
“NSD3 is a histone H3 Lysine 36 (H3K36) methyltransferases, and inhibiting either BRD4 or NSD3 reduces H3K36methylation, a marker of active gene.[33] A short isoform of NSD3 without the methyltrans-”
BackgroundInfluentialWHSC1 links transcription elongation to HIRA‐mediated histone H3.3 deposition
Sarai, N., Nimura, K., Tamura, T., Kanno, T., Patel, M. C., Heightman, T. D., Ura, K., & Ozato, K. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.176 · Cited by 74
“Since trimethylation of H3K36 can be catalysed by multiple Set2-related histone methyltransferases, it is likely that Set2-related enzymes other than WHSC1 are involved in H3K36 methylation (Edmunds et al , 2008; Wang et al , 2008; Nimura et al , 2009; Rahman et al , 2011).”
Inhibition of BRD4 Suppresses Cell Proliferation and Induces Apoptosis in Renal Cell Carcinoma
Wu, X., Liu, D., Gao, X., Xie, F., Tao, D., Xiao, X., Wang, L., Jiang, G., & Zeng, F. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000472407 · Cited by 78
Aiyer, S., Swapna, G. V. T., Malani, N., Aramini, J. M., Schneider, W. M., Plumb, M. R., Ghanem, M., Larue, R. C., Sharma, A., Studamire, B., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku175 · Cited by 72
“Recent studies have identified NSD3, JMJD6, CHD4, GLTSCR1 and ATAD5 proteins as binding partners to the BET family members ET domain (48) and thus the ET domain functions to recruit specific effector proteins to regulate transcriptional activity.”
BackgroundTargeting BET bromodomain proteins in cancer: The example of lymphomas
Spriano, F., Stathis, A., & Bertoni, F. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107631 · Cited by 73
Wang, R., & You, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.600759 · Cited by 77
“It facilitates transcriptional activation by recruiting positive transcription elongation factor b (P-TEFb), mediators, and other transcriptional activators (14, 16, 17).”
BackgroundHo, P. J., Lloyd, S. M., & Bao, X. (2019) · Development · doi:10.1242/dev.178780 · Cited by 73
Targeting lysine acetylation readers and writers
Zhou, M., & Cole, P. A. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01080-6 · Cited by 75
“Their two BrDs bind to Lys-acetylated histones and transcription factors, augmented by the ET domain that also interacts with chromatin and transcription factors 73–75 .”
Suárez-Álvarez, B., Morgado‐Pascual, J. L., Rayego‐Mateos, S., Rodríguez, R. M. A., Rodrigues-Díez, R. R., Cannata‐Ortiz, P., Sanz, A. B., Egido, J., Tharaux, P., Ortíz, A., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015080910 · Cited by 72
9 H -Purine Scaffold Reveals Induced-Fit Pocket Plasticity of the BRD9 Bromodomain
Picaud, S., Strocchia, M., Terracciano, S., Lauro, G., Méndez, J., Daniels, D. L., Riccio, R., Bifulco, G., Bruno, I., & Filippakopoulos, P. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501893k · Cited by 70
The role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumors
Topchu, I., Pangeni, R. P., Bychkov, I., Miller, S. A., Izumchenko, E., Yu, J., Golemis, E. A., Karanicolas, J., & Boumber, Y. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04321-2 · Cited by 72
“For example, the binding of NSD3 to the oncoprotein MYC [61] and the MYC-associated protein BRD4 [104] enhances these proteins' stability and transcriptional activity, driving the expression of genes necessary for transition through the G1/S phases of the cell cycle.”
InfluentialJmjd6, a JmjC Dioxygenase with Many Interaction Partners and Pleiotropic Functions
Kwok, J., O’Shea, M. F., Hume, D. A., & Lengeling, A. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00032 · Cited by 73
“In this context, Jmjd6 protein interaction screens identify several SR- and SRlike proteins, including SRSF2/SC35, among others, as binding partners (Webby et al., 2009; Rahman et al., 2011; Heim et al., 2014) (also see Discussion below on the role of Jmjd6 as a splicing regulatory protein).”
BackgroundGeneral mechanism of JQ1 in inhibiting various types of cancer
Jiang, G., Deng, W., Liu, Y., & Wang, C. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.10927 · Cited by 78
“These distal enhancers are known as anti-pause enhancers, which also suggests that the complexes formed by Brd4, Jmjd6 and P-TeFb bind to chromatin through long-distance interactions, as they are close to the distal and deep promoters of the gene in three-dimensional space, thus regulating transcriptional activation a…”
BackgroundAprelikova, O. N., Chen, K., Touny, L. H. E., Brignatz, C., Han, J. S., Qiu, T., Yang, H. H., Lee, M. P., Zhu, M., & Green, J. E. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0205-6 · Cited by 73
“Several publications identified Brd4 as a binding partner of JMJD6 in different cell types [32, 60, 61].”
Background“Z4” Complex Member Fusions in NUT Carcinoma: Implications for a Novel Oncogenic Mechanism
Shiota, H., Elya, J. E., Alekseyenko, A. A., Chou, P. M., Gorman, S., Barbash, O., Becht, K., Danga, K., Kuroda, M. I., Nardi, V., et al. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0474 · Cited by 71
“Z4 (ZNF592, ZNF532, ZMYND8) components colocalize with and are sequestered by BRD4-NUT We and others had previously shown that ZNF592 and other zinc finger proteins, ZNF532, ZNF687, and ZMYND8, collectively termed "Z4," copurify with BRD4/BRD4-NUT chromatin complex proteins (11, 20).”
BackgroundResultEpigenetic regulation of cardiac fibrosis
Stratton, M. S., & McKinsey, T. A. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.02.011 · Cited by 70
“Furthermore, mass spectrometry studies defining BET partner proteins have suggested that all members of this family can influence chromatin remodeling, methylation, acetylation, and DNA damage response in an acetyl-histone binding-dependent manner [74-76].”
BackgroundWai, D. C. C., Szyszka, T. N., Campbell, A. E., Kwong, C., Wilkinson‐White, L. E., Silva, A. P. G., Low, J. K. K., Kwan, A. H., Gamsjaeger, R., Chalmers, J. D., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000678 · Cited by 73
“Intriguingly, the NuRD subunit CHD4 was among a number of cellular interaction partners identified in pulldowns that used a BRD4 fragment containing the ET domain as bait (46).”
BackgroundInfluentialGauson, E. J., Donaldson, M., Dornan, E. S., Wang, X., Bristol, M. L., Bodily, J. M., & Morgan, I. M. (2015) · Journal of Virology · doi:10.1128/jvi.00335-15 · Cited by 71
“However, 16 Brd4 is required for the optimal transcriptional activation and repression properties of all E2 proteins 17 tested to date (15-34).”
BackgroundThe bromodomain protein BRD4 regulates splicing during heat shock
Hussong, M., Kaehler, C., Kerick, M., Grimm, C., Franz, A., Timmermann, B., Welzel, F., Isensee, J., Hucho, T. B., Krobitsch, S., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw729 · Cited by 70
“As such, BRD4 interacts with the JmjC domain-containing protein 6 (JMJD6), which mediates the 5-hydroxylation of U2AF65 (U2 small nuclear RNA auxillary factor 65) (21,22).”
BackgroundNUT Carcinoma: Clinicopathologic Features, Molecular Genetics and Epigenetics
Moreno, V., Saluja, K., & Piña‐Oviedo, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.860830 · Cited by 66
“Its carboxylterminal domain (CTD), known to interact with the core positive transcription elongation factor b (P-TEFb), is absent (43) (Figure 2).”
BackgroundInfluentialBRD2 compartmentalizes the accessible genome
Xie, L., Dong, P., Qi, Y., Hsieh, T.-H. S., English, B. P., Jung, S., Chen, X., Marzio, M. D., Casellas, R. C., Chang, H. Y., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01044-9 · Cited by 75
“pAG-Tn5 was ordered from EpiCypher (15-1017).”
Heim, A., Grimm, C., Müller, U., Häußler, S., Mackeen, M. M., Merl‐Pham, J., Hauck, S. M., Kessler, B. M., Schofield, C. J., Wolf, A., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku488 · Cited by 67
“HA-tagged Jmjd6 showed the same effect on splicing as untagged Jmjd6 (Figure 9B and G).”
ResultInfluentialWang, R., Liu, W., Helfer, C. M., Bradner, J. E., Hornick, J. L., Janicki, S. M., French, C. A., & You, J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2658 · Cited by 68
“It facilitates transcriptional regulation by recruiting P-TEFb, Mediators and other transcriptional activators (5-7).”
BackgroundInvolvement of Brd4 in different steps of the papillomavirus life cycle
Iftner, T., Haedicke, J., Wu, S.-Y., & Chiang, C. (2016) · Virus Research · doi:10.1016/j.virusres.2016.12.006 · Cited by 66
“As a scaffold protein, Brd4 recruits a variety of transcription factors and chromatin regulators to control transcription (Rahman et al., 2011; Wu et al., 2013).”
BackgroundGarcía-Carpizo, V., Sarmentero, J., Han, B., Graña‐Castro, O., Ruiz‐Llorente, S., Pisano, D. G., Serrano, M., Brooks, H. B., Campbell, R. M., & Barrero, M. J. (2016) · Scientific Reports · doi:10.1038/srep32952 · Cited by 66
Synthesis and evaluation of novel dual BRD4/HDAC inhibitors
Amemiya, S., Yamaguchi, T., Hashimoto, Y., & Noguchi‐Yachide, T. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.04.043 · Cited by 68
Domain-selective targeting of BET proteins in cancer and immunological diseases
Petretich, M., Demont, E. H., & Grandi, P. (2020) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2020.02.003 · Cited by 69
Arginine methylation of BRD4 by PRMT2/4 governs transcription and DNA repair
Liu, L., Lin, B., Yin, S., Ball, L. E., Delaney, J. R., Long, D. T., & Gan, W. (2022) · Science Advances · doi:10.1126/sciadv.add8928 · Cited by 66
Report of the First International Symposium on NUT Carcinoma
French, C. A., Cheng, M. L., Hanna, G. J., DuBois, S. G., Chau, N. G., Hann, C. L., Storck, S., Salgia, R., Trucco, M. M., Tseng, J., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-0591 · Cited by 65
García‐Gutiérrez, P., Mundi, M., & García‐Domínguez, M. (2012) · Journal of Cell Science · doi:10.1242/jcs.105841 · Cited by 69
“While the function of bromodomains has been well characterized, the function of other domains has been poorly investigated (Denis et al., 2000; Rahman et al., 2011).”
BackgroundWang, R., Cao, X.-J., Kulej, K., Liu, W., Ma, T., MacDonald, M., Chiang, C., Garcia, B. A., & You, J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1703071114 · Cited by 70
Huang, Y., Mouttet, B., Warnatz, H.-J., Risch, T., Rietmann, F., Frommelt, F., Ngo, Q. A., Dobay, M. P., Marovca, B., Jenni, S., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.10.004 · Cited by 63
A mechanism for epigenetic control of DNA replication
Sansam, C. G., Pietrzak, K., Majchrzycka, B., Kerlin, M. A., Chen, J., Rankin, S., & Sansam, C. L. (2018) · Genes & Development · doi:10.1101/gad.306464.117 · Cited by 60
BET bromodomains as novel epigenetic targets for brain health and disease
Singh, M. B., & Sartor, G. C. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108306 · Cited by 62
“, NSD3, JMJD6, CHD4) and viral proteins (Rahman et al., 2011; De Rijck et al., 2013; Gupta et al., 2013).”
Tsang, S. H., Wang, X., Li, J., Buck, C. B., & You, J. (2014) · Journal of Virology · doi:10.1128/jvi.03656-13 · Cited by 67
“Brd4 has been shown to interact with the DNA damage response protein ATAD5 (54, 55), suggesting that it may play a role in DNA damage repair-associated viral DNA replication.”
BackgroundHnilicová, J., Hozeifi, S., Stejskalová, E., Dušková, E., Poser, I., Humpolíčková, J., Hof, M., & Staněk, D. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e13-06-0303 · Cited by 60
“Molecular Biology of the Cell associate with several proteins, including the main component of the nucleosome remodeling and deacetylase complex, CHD4; histone-lysine N-methyltransferase, NSD3; and hydroxylase and histone demethylase, JMJD6 (Rahman et al., 2011).”
BackgroundInfluentialASXL3 bridges BRD4 to BAP1 complex and governs enhancer activity in small cell lung cancer
Szczepanski, A. P., Zhao, Z., Sosnowski, T., Goo, Y. A., Bartom, E. T., & Wang, L. (2020) · Genome Medicine · doi:10.1186/s13073-020-00760-3 · Cited by 62
The methyltransferase NSD3 promotes antiviral innate immunity via direct lysine methylation of IRF3
Wang, C., Wang, Q., Xu, X., Xie, B., Zhao, Y. B., Li, N., & Cao, X. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20170856 · Cited by 61
Targeting bromodomain and extraterminal proteins in breast cancer
Sahni, J. M., & Keri, R. A. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.11.015 · Cited by 64
Sánchez-Ventura, J., Amo‐Aparicio, J., Navarro, X., & Penas, C. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1511-7 · Cited by 62
Padmanabhan, A., Alexanian, M., Linares-Saldana, R., González-Terán, B., Andreoletti, G., Huang, Y., Connolly, A. J., Kim, W., Hsu, A., Duan, Q., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.047753 · Cited by 60
Ai, N., Hu, X., Ding, F., Yu, B., Wang, H., Lü, X., Zhang, K., Li, Y., Han, A., Lin, W. Y., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr698 · Cited by 60
“The function of the ET domain is just being recognized as a region interacting with WHSC1L1/NSD3 for P-TEFbindependent regulation of H3K36 methylation (28).”
BackgroundKrämer, K., Moreno, N., Frühwald, M. C., & Kerl, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071537 · Cited by 60
“BET proteins directly influence transcription and cell cycle progression [16,35].”
BackgroundFunctional Roles of Bromodomain Proteins in Cancer
Boyson, S. P., Gao, C., Quinn, K. M., Boyd, J. R., Paculová, H., Frietze, S. E., & Glass, K. C. (2021) · Cancers · doi:10.3390/cancers13143606 · Cited by 61
“The ET domain consists of approximately 80 amino acids, and this region is known to interact with several chromatin effector proteins, including Jumonji Domain Containing 6 (JMJD6), Chromodomain Helicase DNA binding Protein 4 (CHD4), Glioma Tumor Suppressor Candidate Region 1 (GLTSCR1), Nuclear Receptor Binding SET Do…”
BackgroundBRD4: a general regulator of transcription elongation
Altendorfer, E., Mochalova, Y., & Mayer, A. (2022) · Transcription · doi:10.1080/21541264.2022.2108302 · Cited by 62
Michaeloudes, C., Mercado, N., Clarke, C., Bhavsar, P. K., Adcock, I. M., Barnes, P. J., & Chung, K. F. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301984 · Cited by 62
“The interaction of BET proteins with Nrf2 thus possibly occurs through their ET or C-terminal domains either directly or indirectly through other proteins or protein complexes (21, 38, 39).”
BackgroundIntegrated cross-species transcriptional network analysis of metastatic susceptibility
Hu, Y., Wu, G., Rusch, M., Lukes, L., Buetow, K. H., Zhang, J., & Hunter, K. W. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117872109 · Cited by 59
“Additionally, four TPX2 network genes [RFC3, RFC4 (26), JMJD6 (27), CNOT1 (28)] are known to physically interact with the metastasis susceptibility protein BRD4 (19).”
BackgroundThe Role of Chromatin Remodeling in Medulloblastoma
Jones, D., Northcott, P. A., Kool, M., & Pfister, S. M. (2013) · Brain Pathology · doi:10.1111/bpa.12019 · Cited by 62
“More recently, inhibition of bromodomain-containing proteins, which interact with acetylated histones and recruit transcriptional regulators (59), has been suggested as one way of indirectly targeting Myc-driven tumorigenesis (15).”
BackgroundBromodomain protein inhibition: a novel therapeutic strategy in rheumatic diseases
Klein, K. (2018) · RMD Open · doi:10.1136/rmdopen-2018-000744 · Cited by 58
“Additionally, p-TEFb-independent transcriptional activation via the extra-terminal domain of BRD4 has been shown.(41) BRD4 has also kinase activity and binds and phosphorylates RNA Pol II(42) and acetylates H3K122, a residual critical for nucleosome stability, whose acetylation leads to histone eviction.”
BackgroundRole of BET Proteins in Inflammation and CNS Diseases
Liu, L., Yang, C., & Candelario‐Jalil, E. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.748449 · Cited by 60
“ET domain is a protein interaction motif with a highly conserved region of ∼80 amino acids, exhibiting more than 80% identity among BRD2, 3, and 4 (Rahman et al., 2011).”
BackgroundA Comprehensive Review of BET Protein Biochemistry, Physiology, and Pathological Roles
Ali, H. A., Li, Y., Bilal, A. H. M., Qin, T., Yuan, Z., & Zhao, W. H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.818891 · Cited by 60
Viral–Host Interactions That Control HIV-1 Transcriptional Elongation
Lu, H., Li, Z., Xue, Y., & Zhou, Q. (2013) · Chemical Reviews · doi:10.1021/cr400120z · Cited by 62
Phospho-BRD4: transcription plasticity and drug targeting
Chiang, C. (2016) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2016.05.003 · Cited by 57
“structurally defined ET domain [8] that interacts with specific chromatin regulators, including NSD3, JMJD6, CHD4, GLTSCR1, and ATAD5 [9,10].”
BackgroundInfluentialFang, Y., Tang, Y., Zhang, Y., Pan, Y., Jia, J., Sun, Z., Zeng, W., Chen, J., Yuan, Y., & Dong, F. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab473 · Cited by 56
“As previously reported (56,57), we detected several bromodomain-containing proteins in the purification of NSD1, including PBRM1, BRD2, BRD4 and BAZ1A, confirming the success of IP experiments.”
BackgroundBerkovits, B. D., Wang, L., Guarnieri, P., & Wolgemuth, D. J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks342 · Cited by 58
“BRD4 also has a P-TEFb-independent role in transcriptional regulation that involves recruiting the histone–lysine Nmethyltransferase NSD3 to promoter regions (15).”
Zhou, Y., Yan, X., Feng, X., Bu, J., Dong, Y., Lin, P., Hayashi, Y., Huang, R., Olsson, A., Andreassen, P. R., et al. (2018) · Haematologica · doi:10.3324/haematol.2018.187708 · Cited by 58
BRD4 promotes resection and homology-directed repair of DNA double-strand breaks
Barrows, J. K., Lin, B., Quaas, C. E., Fullbright, G., Wallace, E. N., & Long, D. T. (2022) · Nature Communications · doi:10.1038/s41467-022-30787-6 · Cited by 56
The double bromodomain protein Brd2 promotes B cell expansion and mitogenesis
Belkina, A. C., Blanton, W. P., Nikolajczyk, B. S., & Denis, G. V. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1112588 · Cited by 57
“The Brd4 ET domain recruits chromatin-modifying enzymes and transcription factors that confer specificity to target loci [22].”
BackgroundDonato, E., Croci, O., Sabò, A., Müller, H., Morelli, M. J., Pelizzola, M., & Campaner, S. (2016) · Leukemia · doi:10.1038/leu.2016.182 · Cited by 54
The Bromodomain Protein 4 Contributes to the Regulation of Alternative Splicing
Uppal, S., Gégonne, A., Chen, Q., Thompson, P. S., Cheng, D., Mu, J., Meerzaman, D. M., Misra, H. S., & Singer, D. S. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.066 · Cited by 56
“Using N-terminal and Cterminal truncations of rBRD4, the binding site of FUS was mapped to the N terminus, validating the previous mass spec results (Rahman et al., 2011) (Figure 4E).”
BackgroundResultInfluentialThe emerging role of BET inhibitors in breast cancer
Andrikopoulou, Α., Liontos, M., Koutsoukos, K., Dimopoulos, M. A., & Zagouri, F. (2020) · The Breast · doi:10.1016/j.breast.2020.08.005 · Cited by 54
“BRD3 and BRD4 synergize with WHSC1 to regulate estrogen receptor A (ERa) expression, a gene that encodes histone-lysine N-methyltransferase NSD2 that methylates H3K36, a key event for transcription elongation [10].”
BackgroundAhmed, N. S., Gatchalian, J., Ho, J., Burns, M. J., Hah, N., Wei, Z., Downes, M., Evans, R. M., & Hargreaves, D. C. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2110812119 · Cited by 51
“Based on our work and others demonstrating a biochemical interaction between BRD9 and the BET proteins BRD4 (9, 10, 12, 21) and BRD2 (12) and a similar effect of BRD9 and BET protein inhibition on transcription in other systems (10, 12), we included an additional treatment with JQ1 (18), a BET bromodomain inhibitor, i…”
BackgroundCotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer
Zhu, X., Fu, Z., Dutchak, K., Arabzadeh, A., Milette, S., Steinberger, J., Morin, G., Monast, A., Pilon, V., Kong, T., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-1749 · Cited by 56
Rice DECUSSATE controls phyllotaxy by affecting the cytokinin signaling pathway
Itoh, J.-I., Hibara, K., Kojima, M., Sakakibara, H., & Nagato, Y. (2012) · The Plant Journal · doi:10.1111/j.1365-313x.2012.05123.x · Cited by 51
The therapeutic potential of epigenetic manipulation during infectious diseases
Cole, J., Morris, P., Dickman, M. J., & Dockrell, D. H. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.07.013 · Cited by 52
“The precise role of JMJD6 remains unclear; it was initially thought to be a histone arginine demethylase (Chang, Chen, Zhao, & Bruick, 2007) but more recently has been described as a hydroxylase involved in regulating RNA splicing (Webby et al., 2009).”
BackgroundJia, Y., Shen, H., Qiu, J., Huang, M., Zhang, W., Ding, J., Zhu, X., Zhou, Y., Fu, X., & Liu, W. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1144 · Cited by 51
“Besides its function in transcriptional control, we and others have shown that JMJD6 also interacts with multiple arginine–serine-rich (RS) domains of SR proteins and SRlike splicing factors, including U2AF65, suggesting JMJD6 may be involved in splicing regulation (31,39,41,42).”
BackgroundEpigenetic Aberrations in Multiple Myeloma
Caprio, C., Sacco, A., Giustini, V., & Roccaro, A. M. (2020) · Cancers · doi:10.3390/cancers12102996 · Cited by 47
“BRD-proteins promotes the recruitment of transcriptional activators, thus enhancing transcriptional activation [82].”
BackgroundSmall Molecule Bromodomain Inhibitors
Chung, C. (2012) · Progress in medicinal chemistry · doi:10.1016/b978-0-12-396493-9.00001-7 · Cited by 50
Hilton, J. F., Cristea, M. C., Postel-Vinay, S. C., Baldini, C., Voskoboynik, M., Edenfield, W. J., Shapiro, G. I., Cheng, M. L., Vuky, J., Corr, B. R., et al. (2022) · Cancers · doi:10.3390/cancers14174079 · Cited by 49
“Bromodomain and extraterminal domain (BET) proteins (including bromodomain-containing [BRD] proteins BRD2, BRD3, BRD4, and BRD testisspecific [BRDT] protein) act as readers of acetylated lysine histone residues and recruit regulatory complexes for transcriptional modulation [3,5,6].”
BackgroundGenomic targeting of epigenetic probes using a chemically tailored Cas9 system
Liszczak, G., Brown, Z. Z., Kim, S. H., Oslund, R., David, Y., & Muir, T. W. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1615723114 · Cited by 49
“This finding suggests that endogenous BET proteins, which are known transcriptional coactivators (30, 31), are recruited by dCas9-JQ1 and can activate luciferase expression, albeit to a lesser degree than the VP64-Brd4T-VP64 fusion.”
Background
Metadata
- Authors
- Rahman, S., Sowa, M. E., Ottinger, M., Smith, J. A., Shi, Y., Harper, J. W., & Howley, P. M.
- Affiliations
- Harvard University (US)
- Corresponding author
- Howley, Peter M.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2011-07-01
- Volume
- 31
- Issue
- 13
- Pages
- 2641-2652
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC3133372
- OpenAlex
- W2167732604
- Cited by
- 532
- References
- 60
- Citations by year
- 2026: 25 · 2025: 14 · 2024: 41 · 2023: 39 · 2022: 35 · 2021: 55 · 2020: 37 · 2019: 41 · 2018: 39 · 2017: 42 · 2016: 40 · 2015: 30 · 2014: 27 · 2013: 33 · 2012: 27
- FWCI
- 12.22
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Molecular and Cellular Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (AG011085, R01AG011085)
- National Cancer Institute (T32CA009361, R01CA116720)
- National Institute of General Medical Sciences (GM054137, R01GM054137, R01GM070565)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- BRD4, NSD3, JMJD6, ATAD5, CHD4, H3K36 methylation, chromatin recruitment, BET proteins, BRD2, BRD3, protein-protein interaction, histone modifications
- MeSH terms
- Bromodomain Containing Proteins, Amino Acid Sequence, Cell Line, Chromosomal Proteins, Non-Histone, Humans, Molecular Sequence Data, Nuclear Proteins, Histone-Lysine N-Methyltransferase, Transcription Factors, Transcriptional Activation, Protein Structure, Tertiary, Cell Cycle Proteins, Tumor Suppressor Proteins, Positive Transcriptional Elongation Factor B, Jumonji Domain-Containing Histone Demethylases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.